<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03917823</url>
  </required_header>
  <id_info>
    <org_study_id>Cryoneurolysis &amp; Rib Fracture</org_study_id>
    <nct_id>NCT03917823</nct_id>
  </id_info>
  <brief_title>Intercostal Cryoneurolysis Following Traumatic Rib Fractures</brief_title>
  <official_title>Intercostal Cryoneurolysis Following Traumatic Rib Fractures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rib fractures are one of the most common injuries in trauma patients. These fractures are&#xD;
      associated with significant pain as well as decreased ability to inspire deeply or cough to&#xD;
      clear secretions, which together lead to pulmonary complications and a high degree of&#xD;
      morbidity and mortality. Peripheral nerve blocks as well as epidural blocks have been used&#xD;
      with success to improve pain control in rib fracture patients and have been associated with&#xD;
      decreased pulmonary complications and improved outcomes. However, a single-injection nerve&#xD;
      block lasts less than 24 hours; and, even a continuous nerve block is generally limited to&#xD;
      3-4 days. The pain from rib fractures usually persists for multiple weeks or months. In&#xD;
      contrast to local anesthetic-induced nerve blocks, a prolonged block lasting a few&#xD;
      weeks/months may be provided by freezing the nerve using a process called &quot;cryoneurolysis&quot;.&#xD;
      The goal of this randomized, double-masked, sham-controlled study is to evaluate the&#xD;
      potential of cryoanalgesia to decrease pain and improve pulmonary mechanics in patients with&#xD;
      rib fractures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rib fractures represent a significant source of morbidity in trauma patients, with&#xD;
      approximately 10% of trauma patients presenting with rib fractures.1 Pain from rib fractures&#xD;
      is associated with decreased ability to cough and inspire deeply, predisposing patients to&#xD;
      atelectasis and pulmonary complications. Neuraxial blocks, both thoracic epidurals and&#xD;
      paravertebral blocks, have been associated not only with decreased pain, but also decreased&#xD;
      pulmonary complications and overall mortality in patients with rib fractures.2 Furthermore,&#xD;
      intercostal nerve blocks with local anesthetic have been shown to improve pain scores, peak&#xD;
      expiratory flow rates, and arterial oxygen saturation on room air.3 However, intercostal&#xD;
      nerve blocks are not without risk and incidence of pneumothorax has been reported as 1.4% for&#xD;
      each individual intercostal nerve that is blocked.4 Although it is possible that the use of&#xD;
      in-plane ultrasound guidance may decrease the risk of pneumothorax, this has not been&#xD;
      evaluated. Additionally, intercostal blocks with bupivacaine have been reported to resolve in&#xD;
      as little as six hours,5 likely due to the high vascularity and consequent uptake of local&#xD;
      anesthetic from the intercostal space.&#xD;
&#xD;
      An alternative analgesic technique is cryoneurolysis, consisting of the application of&#xD;
      exceptionally low temperatures to reversibly ablate peripheral nerves, resulting in temporary&#xD;
      pain relief termed &quot;cryoanalgesia&quot;.6 The intense cold temperature at the probe tip produces&#xD;
      Wallerian degeneration-a reversible breakdown of the nerve axon-subsequently inhibiting&#xD;
      transmission of afferent and efferent signals. Because the nerve endoneurium, perineurium,&#xD;
      and epineurium remain intact, the axon regenerates along the exoskeleton at a rate of&#xD;
      approximately 1-2 mm/day. While cryoneurolysis of peripheral nerves through surgical&#xD;
      incisions has been commonly used to treat pain since 1961, the development of cryo probes&#xD;
      that may be inserted percutaneously promise a revolution in the use of this modality. The&#xD;
      combination of newly-designed narrow-gauge probes (upper right) and ultrasound now make&#xD;
      percutaneous cryoanalgesia as simple as placing a peripheral nerve block: the probe tip is&#xD;
      inserted adjacent to the target nerve under ultrasound guidance, and a series of 2-minute&#xD;
      freezing cycles are administered followed by probe withdrawal. The procedure is essentially&#xD;
      the same as placing an ultrasound-guided peripheral nerve block; however, instead of&#xD;
      injecting local anesthetic, a gas circulates through the probe, inducing cold at the tip and&#xD;
      freezing the target nerve. Nothing remains within the patient and there is no external&#xD;
      equipment to prepare or manage. Importantly, cryoneurolysis and the probes are already&#xD;
      approved by the United States Food and Drug Administration for the treatment of acute and&#xD;
      chronic pain, so no additional regulatory approval is required for the proposed clinical&#xD;
      trial.&#xD;
&#xD;
      Theoretical benefits of cryoneurolysis include an ultra-long duration of pain control without&#xD;
      opioid involvement, no catheter management/removal (reducing infection risk), the lack of an&#xD;
      infusion pump and anesthetic reservoir to carry, an extraordinarily-low risk of infection&#xD;
      (approaching zero), and no risk of local anesthetic toxicity, catheter dislodgement or&#xD;
      leakage. With a single 8-minute percutaneous cryoneurolysis procedure consisting of several&#xD;
      freeze/defrost cycles, a truncation of sensory nerve conduction is induced for 6-8 weeks,&#xD;
      with the complete restoration of nerve structure and function following remyelination.&#xD;
      Cryoneurolysis offers the possibility of potent, side effect-free analgesia outlasting the&#xD;
      surgical pain, and obviating the need for postoperative opioids.&#xD;
&#xD;
      All subjects would continue to receive standard and customary analgesics, so there is no risk&#xD;
      of subjects receiving a lower degree of analgesia than if they otherwise did not enroll in&#xD;
      the study. The cryoneurolysis procedure will be done in addition to the investigator's&#xD;
      current UCSD standard practice.&#xD;
&#xD;
      Study Overview&#xD;
&#xD;
      Day 0 Subjects randomized and cryoneurolysis/sham procedure administered&#xD;
&#xD;
      Days 0-4, 7, 14, 21, and Months 1, 3, 6 Data collection&#xD;
&#xD;
      Subjects will be individuals who present to one of the UCSD hospitals with rib fracture(s)&#xD;
      and significant pain. Those who consent to participate in this study will have standard&#xD;
      intercostal nerve blocks administered.&#xD;
&#xD;
      Treatment group assignment (randomization). Subjects will be allocated to one of two possible&#xD;
      treatments:&#xD;
&#xD;
        1. cryoneurolysis&#xD;
&#xD;
        2. sham procedure (placebo control)&#xD;
&#xD;
      Computer-generated randomization lists will be used to create sealed, opaque randomization&#xD;
      envelopes with the treatment group assignment enclosed in each envelope labeled with the&#xD;
      randomization number.&#xD;
&#xD;
      The specific intercostal nerves targeted will depend on the injury site. The cryoneurolysis&#xD;
      sites will be cleansed with chlorhexidine gluconate and isopropyl alcohol. Using the optimal&#xD;
      ultrasound transducer for the specific anatomic location and subject anatomy (linear vs&#xD;
      curvilinear array), the target nerves will be identified in a transverse cross-sectional&#xD;
      (short axis) view.&#xD;
&#xD;
      Cryoneurolysis Procedure: Cryoneurolysis probes are available for a console neurolysis device&#xD;
      (PainBlocker, Epimed, Farmers Branch, Texas) that either (1) pass nitrous oxide to the tip&#xD;
      inducing freezing temperatures; or, (2) vent the nitrous oxide at the base of the probe so&#xD;
      that no gas reaches the probe tip, resulting in no temperature change. The latter is a sham&#xD;
      procedure since without the temperature change, no ice ball forms and therefore the target&#xD;
      nerve is not affected. An angiocatheter/introducer may be inserted beneath the ultrasound&#xD;
      transducer and directed until the probe tip is immediately adjacent to the target nerve&#xD;
      (lidocaine 1% will be administered, as needed, to anesthetize the angiocatheter track). The&#xD;
      target nerves will be the intercostal nerves above and below each fractured rib. The&#xD;
      angiocatheter needle will be removed, leaving the angiocatheter through which the appropriate&#xD;
      Epimed probe will be inserted until it is adjacent to the target nerve. The cryoneurolysis&#xD;
      device will be triggered using 3 cycles of 2-minute gas activation (active or sham) separated&#xD;
      by 1-minute defrost periods. For active probes, the nitrous oxide will be deployed to the tip&#xD;
      where a drop in temperature to -70Â°C will result in cryoneurolysis. For the sham probes, the&#xD;
      nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of&#xD;
      perineural temperature change. The process will be repeated with the same treatment probe for&#xD;
      any additional nerves (e.g., all nerves will receive either active cryoneurolysis or&#xD;
      sham/placebo, and not a mix of the two possible treatments).&#xD;
&#xD;
      Statistical Analysis: The primary endpoint is average pain score the day following treatment.&#xD;
      The primary inference will be based on the Mann-Whitney U test of the difference between&#xD;
      groups with an exact test with two-sided Type I error of 5%. Highest spirometry reading for&#xD;
      each period of time will be the secondary end point of highest interest [so designated after&#xD;
      the 4th subject was enrolled on September 23, 2019].&#xD;
&#xD;
      Patient baseline characteristics will be summarized by group with mean, standard deviation,&#xD;
      quartiles, range, and boxplots for continuous data; and counts and percentages for binary and&#xD;
      categorical data. Group differences will be assessed with Mann-Whitney U test for continuous&#xD;
      data and Pearson chi-square test for categorical data. If any key characteristics are&#xD;
      significantly different between groups, a proportional odds model will be used to test for a&#xD;
      group difference in the primary outcome adjusting for the potential confounding variable.&#xD;
&#xD;
      Pilot parameters for sample size justification are based on Osinowo et al (2004).3 Of the&#xD;
      initial pain scores for n=21 patients, n=18 (86%) had scores of 3.0 and n=3 (14%) had scores&#xD;
      of 2.0 (mean 2.86 Â± 0.36). After 24 hours n=13 (62%) had scores of 0 and n=8 (38%) had scores&#xD;
      of 1.0 (mean 0.38 Â± 0.50).&#xD;
&#xD;
      To simulate power with Mann-Whitney U test, we simulate controls groups assuming the&#xD;
      distribution of initial average pain scores from Osinowo et al. scores in the cryoneurolysis&#xD;
      groups are simulated assuming a score distribution 10% 0, 15% 1, 25% 2, and 50% 3 (resulting&#xD;
      in mean 2.12 Â± 1.04 compared to control group mean 2.86 Â± 0.36).&#xD;
&#xD;
      Under these assumptions a sample size of n=25 per group attains power 84% with two-sided Type&#xD;
      I error 5%. To allow for drop-outs, we will enroll up to a maximum of 60 subjects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Revised protocol to such a significant degree that we simply closed this study and started a&#xD;
    new study.&#xD;
  </why_stopped>
  <start_date type="Actual">April 20, 2019</start_date>
  <completion_date type="Actual">March 25, 2020</completion_date>
  <primary_completion_date type="Actual">September 24, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, double-masked, sham-controlled, parallel-arm human subjects clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
    <masking_description>Cryoneurolysis probes are available for a console neurolysis device (PainBlocker, Epimed, Farmers Branch, Texas) that either (1) pass nitrous oxide to the tip inducing freezing temperatures; or, (2) vent the nitrous oxide at the base of the probe so that no gas reaches the probe tip, resulting in no temperature change. The latter is a sham procedure since without the temperature change, no ice ball forms and therefore the target nerve is not affected.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Average Resting Pain Score</measure>
    <time_frame>Day following treatment</time_frame>
    <description>Pain score measured using the numeric rating scale for pain: 0=no pain and 10=worst imaginable pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average Pain Score</measure>
    <time_frame>Days 2-4, Weeks 1-3, Months 1,3,6</time_frame>
    <description>Pain score measured using the numeric rating scale for pain: 0=no pain and 10=worst imaginable pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worst Pain Score</measure>
    <time_frame>Days 1-4, weeks 1-4, months 3 &amp; 6</time_frame>
    <description>Pain score measured using the numeric rating scale for pain: 0=no pain and 10=worst imaginable pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Opioid Consumption</measure>
    <time_frame>Days 1-4, 7, 14, 21, and months 1, 3 and 6</time_frame>
    <description>Number of opioid tablets consumed previous 24 hours (oxycodone 5 mg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incentive Spirometer Volume</measure>
    <time_frame>Days 1-4, 7, 14, and 21</time_frame>
    <description>maximum incentive spirometer volume</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">4</enrollment>
  <condition>Rib Fractures</condition>
  <arm_group>
    <arm_group_label>Cryoneurolysis (active)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation (active or sham) separated by 1-minute defrost periods.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cryoneurolysis</intervention_name>
    <description>The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation separated by 1-minute defrost periods for the target intercostal nerves.</description>
    <arm_group_label>Cryoneurolysis (active)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham comparator</intervention_name>
    <description>For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients of at least 18 years of age&#xD;
&#xD;
          -  having 1-3 sustained rib fractures on either or both sides (if bilateral fractures,&#xD;
             then total up to 6 fractures with up to 3 per side)&#xD;
&#xD;
          -  regional anesthetic requested by the admitting service&#xD;
&#xD;
          -  accepting of a cryoneurolysis procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  chronic opioid use (daily use within the 2 weeks prior to surgery and duration of use&#xD;
             &gt; 4 weeks&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  incarceration&#xD;
&#xD;
          -  inability to communicate with the investigators&#xD;
&#xD;
          -  morbid obesity (body mass index &gt; 40 kg/m2)&#xD;
&#xD;
          -  possessing any contraindication specific to cryoneurolysis such as a localized&#xD;
             infection at the treatment site, cryoglobulinemia, cold urticaria and Reynaud's&#xD;
             Syndrome&#xD;
&#xD;
          -  any patient unable to correctly perform incentive spirometry as this is an outcome&#xD;
             measure&#xD;
&#xD;
          -  any patient with any degree of decreased mental capacity as determined by the surgical&#xD;
             service&#xD;
&#xD;
          -  any reason an investigator believes study participation would not be in the best&#xD;
             interest of the potential subject, including an anti-coagulated state&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>April 13, 2019</study_first_submitted>
  <study_first_submitted_qc>April 16, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2019</study_first_posted>
  <results_first_submitted>January 30, 2021</results_first_submitted>
  <results_first_submitted_qc>February 18, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">March 11, 2021</results_first_posted>
  <last_update_submitted>February 18, 2021</last_update_submitted>
  <last_update_submitted_qc>February 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Brian M. Ilfeld, MD, MS</investigator_full_name>
    <investigator_title>Professor of Anesthesiology, In Residence</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Rib Fractures</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 19, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/23/NCT03917823/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Cryoneurolysis (Active)</title>
          <description>The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation (active or sham) separated by 1-minute defrost periods.&#xD;
Cryoneurolysis: The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation separated by 1-minute defrost periods for the target intercostal nerves.</description>
        </group>
        <group group_id="P2">
          <title>Sham</title>
          <description>For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.&#xD;
Sham comparator: For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cryoneurolysis (Active)</title>
          <description>The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation (active or sham) separated by 1-minute defrost periods.&#xD;
Cryoneurolysis: The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation separated by 1-minute defrost periods for the target intercostal nerves.</description>
        </group>
        <group group_id="B2">
          <title>Sham</title>
          <description>For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.&#xD;
Sham comparator: For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="2"/>
            <count group_id="B2" value="2"/>
            <count group_id="B3" value="4"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2"/>
                    <count group_id="B2" value="2"/>
                    <count group_id="B3" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.5" lower_limit="55" upper_limit="64"/>
                    <measurement group_id="B2" value="54.5" lower_limit="43" upper_limit="66"/>
                    <measurement group_id="B3" value="57.0" lower_limit="43" upper_limit="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2"/>
                    <count group_id="B2" value="2"/>
                    <count group_id="B3" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2"/>
                    <count group_id="B2" value="2"/>
                    <count group_id="B3" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Height (m)</title>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2"/>
                    <count group_id="B2" value="2"/>
                    <count group_id="B3" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.75" lower_limit="1.7" upper_limit="1.8"/>
                    <measurement group_id="B2" value="1.75" lower_limit="1.7" upper_limit="1.8"/>
                    <measurement group_id="B3" value="1.75" lower_limit="1.7" upper_limit="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight (kg)</title>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="2"/>
                    <count group_id="B2" value="2"/>
                    <count group_id="B3" value="4"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93.0" lower_limit="68" upper_limit="118"/>
                    <measurement group_id="B2" value="97.6" lower_limit="90.4" upper_limit="104.8"/>
                    <measurement group_id="B3" value="95.3" lower_limit="68" upper_limit="118"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Average Resting Pain Score</title>
        <description>Pain score measured using the numeric rating scale for pain: 0=no pain and 10=worst imaginable pain</description>
        <time_frame>Day following treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Cryoneurolysis (Active)</title>
            <description>The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation (active or sham) separated by 1-minute defrost periods.&#xD;
Cryoneurolysis: The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation separated by 1-minute defrost periods for the target intercostal nerves.</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.&#xD;
Sham comparator: For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Resting Pain Score</title>
          <description>Pain score measured using the numeric rating scale for pain: 0=no pain and 10=worst imaginable pain</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="2.8"/>
                    <measurement group_id="O2" value="8.3" spread="1.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Pain Score</title>
        <description>Pain score measured using the numeric rating scale for pain: 0=no pain and 10=worst imaginable pain</description>
        <time_frame>Days 2-4, Weeks 1-3, Months 1,3,6</time_frame>
        <population>One subject from the treatment/experimental group could not be reached Months 3 and 6; one subject from the control group dropped out after postoperative day 1; and one subject from the control group could not be reached Month 6</population>
        <group_list>
          <group group_id="O1">
            <title>Cryoneurolysis (Active)</title>
            <description>The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation (active or sham) separated by 1-minute defrost periods.&#xD;
Cryoneurolysis: The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation separated by 1-minute defrost periods for the target intercostal nerves.</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.&#xD;
Sham comparator: For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Pain Score</title>
          <description>Pain score measured using the numeric rating scale for pain: 0=no pain and 10=worst imaginable pain</description>
          <population>One subject from the treatment/experimental group could not be reached Months 3 and 6; one subject from the control group dropped out after postoperative day 1; and one subject from the control group could not be reached Month 6</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="2.1"/>
                    <measurement group_id="O2" value="8.3" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="4.9"/>
                    <measurement group_id="O2" value="8.5" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="2.1"/>
                    <measurement group_id="O2" value="8.0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="2.8"/>
                    <measurement group_id="O2" value="8.0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="1.4"/>
                    <measurement group_id="O2" value="4.5" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="1.4"/>
                    <measurement group_id="O2" value="3.5" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="1.4"/>
                    <measurement group_id="O2" value="4.5" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="0"/>
                    <measurement group_id="O2" value="3.0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Worst Pain Score</title>
        <description>Pain score measured using the numeric rating scale for pain: 0=no pain and 10=worst imaginable pain</description>
        <time_frame>Days 1-4, weeks 1-4, months 3 &amp; 6</time_frame>
        <population>One patient withdrew and 2 patients were lost to follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>Cryoneurolysis (Active)</title>
            <description>The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation (active or sham) separated by 1-minute defrost periods.&#xD;
Cryoneurolysis: The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation separated by 1-minute defrost periods for the target intercostal nerves.</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.&#xD;
Sham comparator: For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.</description>
          </group>
        </group_list>
        <measure>
          <title>Worst Pain Score</title>
          <description>Pain score measured using the numeric rating scale for pain: 0=no pain and 10=worst imaginable pain</description>
          <population>One patient withdrew and 2 patients were lost to follow-up</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" spread="3.5"/>
                    <measurement group_id="O2" value="9.8" spread="0.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" spread="5.7"/>
                    <measurement group_id="O2" value="9.5" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.3" spread="6"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="4.9"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="4.6"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.5" spread="4.9"/>
                    <measurement group_id="O2" value="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="4.2"/>
                    <measurement group_id="O2" value="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.0" spread="4.2"/>
                    <measurement group_id="O2" value="5.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.5"/>
                    <measurement group_id="O2" value="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Opioid Consumption</title>
        <description>Number of opioid tablets consumed previous 24 hours (oxycodone 5 mg)</description>
        <time_frame>Days 1-4, 7, 14, 21, and months 1, 3 and 6</time_frame>
        <population>One subject withdrew and two subjects were lost to follow-up</population>
        <group_list>
          <group group_id="O1">
            <title>Cryoneurolysis (Active)</title>
            <description>The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation (active or sham) separated by 1-minute defrost periods.&#xD;
Cryoneurolysis: The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation separated by 1-minute defrost periods for the target intercostal nerves.</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.&#xD;
Sham comparator: For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.</description>
          </group>
        </group_list>
        <measure>
          <title>Opioid Consumption</title>
          <description>Number of opioid tablets consumed previous 24 hours (oxycodone 5 mg)</description>
          <population>One subject withdrew and two subjects were lost to follow-up</population>
          <units>opioid tablets (5mg oxycodone)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.5" spread="6.5"/>
                    <measurement group_id="O2" value="2.8" spread="3.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.7"/>
                    <measurement group_id="O2" value="14.5" spread="4.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="1.4"/>
                    <measurement group_id="O2" value="18" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.0" spread="1.4"/>
                    <measurement group_id="O2" value="24.0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="2.8"/>
                    <measurement group_id="O2" value="22.0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="2.8"/>
                    <measurement group_id="O2" value="10" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="2.1"/>
                    <measurement group_id="O2" value="12.0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Week 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.7"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                    <measurement group_id="O2" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Month 6</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="1"/>
                    <count group_id="O2" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0" spread="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incentive Spirometer Volume</title>
        <description>maximum incentive spirometer volume</description>
        <time_frame>Days 1-4, 7, 14, and 21</time_frame>
        <population>some subjects were lost to follow-up and one withdrew</population>
        <group_list>
          <group group_id="O1">
            <title>Cryoneurolysis (Active)</title>
            <description>The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation (active or sham) separated by 1-minute defrost periods.&#xD;
Cryoneurolysis: The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation separated by 1-minute defrost periods for the target intercostal nerves.</description>
          </group>
          <group group_id="O2">
            <title>Sham</title>
            <description>For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.&#xD;
Sham comparator: For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.</description>
          </group>
        </group_list>
        <measure>
          <title>Incentive Spirometer Volume</title>
          <description>maximum incentive spirometer volume</description>
          <population>some subjects were lost to follow-up and one withdrew</population>
          <units>mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2625" spread="530"/>
                    <measurement group_id="O2" value="1675" spread="1520"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="2"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2375" spread="177"/>
                    <measurement group_id="O2" value="1575" spread="1662"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2500" spread="354"/>
                    <measurement group_id="O2" value="500"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2875" spread="884"/>
                    <measurement group_id="O2" value="500"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 7</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2750" spread="707"/>
                    <measurement group_id="O2" value="750"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 14</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2875" spread="884"/>
                    <measurement group_id="O2" value="1250"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 21</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="1"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2875" spread="884"/>
                    <measurement group_id="O2" value="1250"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Cryoneurolysis (Active)</title>
          <description>The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation (active or sham) separated by 1-minute defrost periods.&#xD;
Cryoneurolysis: The cryoneurolysis device will be triggered using 3 cycles of 2-minute gas activation separated by 1-minute defrost periods for the target intercostal nerves.</description>
        </group>
        <group group_id="E2">
          <title>Sham</title>
          <description>For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.&#xD;
Sham comparator: For the sham probes, the nitrous oxide will be vented prior to reaching the probe shaft, resulting in a lack of perineural temperature change.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="2"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="2"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Brian Ilfeld, MD, MS</name_or_title>
      <organization>University of California San Diego</organization>
      <phone>858-822-0776</phone>
      <email>bilfeld@health.ucsd.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

